Cornercap Investment Counsel’s John Wiley & Sons Class A WLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,391
Closed -$367K 452
2024
Q4
$367K Sell
8,391
-2,609
-24% -$128K 0.12% 300
2024
Q3
$531K Sell
11,000
-19,339
-64% -$888K 0.16% 223
2024
Q2
$1.23M Sell
30,339
-271
-0.9% -$10.3K 0.2% 139
2024
Q1
$1.17M Hold
30,610
0.18% 182
2023
Q4
$972K Buy
30,610
+5,088
+20% +$159K 0.16% 268
2023
Q3
$949K Sell
25,522
-4,301
-14% -$153K 0.17% 225
2023
Q2
$1.01M Buy
+29,823
New +$1.09M 0.18% 216
2022
Q2
Sell
-18,696
Closed -$991K 698
2022
Q1
$991K Sell
18,696
-647
-3% -$34K 0.11% 324
2021
Q4
$1.11M Buy
+19,343
New +$1.05M 0.16% 245
2020
Q4
Sell
-28,408
Closed -$901K 618
2020
Q3
$901K Buy
+28,408
New +$963K 0.13% 246
2018
Q1
Sell
-13,135
Closed -$864K 452
2017
Q4
$864K Buy
13,135
+2,590
+25% +$150K 0.12% 203
2017
Q3
$564K Sell
10,545
-460
-4% -$24.7K 0.08% 354
2017
Q2
$581K Buy
+11,005
New +$575K 0.1% 256

Other funds holding WLY

Cornercap Investment Counsel's WLY Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of John Wiley & Sons Class A (WLY) in Q1 2025, closing a stake of 8,391 shares — an estimated $367K sold.

Cornercap Investment Counsel first reported a position in WLY in Q2 2017 and held it in 13 quarters. The position peaked at $1.23M in Q2 2024. 255 funds tracked by Wall St. Rank hold WLY as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining John Wiley & Sons Class A position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 8,391 John Wiley & Sons Class A shares in Q1 2025, an estimated $367K.
  • Cornercap Investment Counsel first reported a position in John Wiley & Sons Class A in Q2 2017 and held it in 13 quarters.
  • Cornercap Investment Counsel's John Wiley & Sons Class A position peaked at $1.23M in Q2 2024.
  • 255 funds tracked by Wall St. Rank held John Wiley & Sons Class A as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.